Evidence and implications of mortality associated with acute plasmodium vivax malaria

Clinical Microbiology Reviews

Volumn 26, Issue 1, 2013, Pages 36-57

  Kevin Baird, J ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAFENOQUINE;

ANEMIA; ARTICLE; COMORBIDITY; DISEASE SEVERITY; HUMAN; HYPERPYREXIA; INFECTION CONTROL; INFECTION RISK; MORBIDITY; MORTALITY; NEUROSYPHILIS; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PLASMODIUM KNOWLESI; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION;

BLOOD; BONE MARROW; HUMANS; MALARIA, VIVAX; PARASITEMIA; PLASMODIUM VIVAX; SPLEEN;

PLASMODIUM VIVAX;

EID: 84872174113     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00074-12     Document Type: Article

References (175)

1. Mendis K, Sina BJ, Marchesini P, Carter R. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
2. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI. 2010. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl. Trop. Dis. 4:e774. doi:10.1371/journal.pntd.0000774.
3. Guerra CA, Snow RW, Hay SI. 2006. Mapping the global extent of malaria in 2005. Trends Parasitol. 22:353-358.
4. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. 2005. The global distribution of clinical episodes of Plasmodium falciparum. Nature 434: 214-217.
5. Gething PW, Elyazar IRF, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HFL, Price RN, Müeller I, Baird JK, Hay SI. 2012. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl. Trop. Dis. 6:e1814. doi:10.1371/journal.pntd.0001814.
6. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-304.
7. Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Menard D, Williams TN, Weatherall DJ, Hay SI. 2011. The global distribution of the Duffy blood group. Nat. Commun. 2:266.
8. Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW. 2010. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med. 7:e1000290. doi:10.1371/journal.pmed.1000290.
9. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. 2004. The global distribution and population at risk of malaria: past, present and future. Lancet 4:327-336.
10. World Health Organization. 2010. World malaria report 2010. World Health Organization, Geneva, Switzerland.
11. Project UNM, Working Group on Malaria. 2005. Coming to grips with malaria in the new millenium. Task force on HIV/AIDS, malaria, TB and access to essential medicines. Earthscan, London, United Kingdom.
12. Breman JG, Alilio MS, Mills A. 2004. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg. 71(Suppl 2):1-15.
13. Finkel M. 2007. Bedlam in the blood: malaria. Natl. Geogr. July 2007: 31-67.
14. PATH. 2011. Staying the course? Malaria research and development in a time of economic uncertainty. PATH, Seattle, WA.
15. Snow RW, Okiro EA, Gething PW, Atun R, Hay SI. 2010. Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments. Lancet 376:1409-1416.
16. Piggott DM, Atun R, Moyes CL, Hay SI, Gething PW. 2012. Funding for malaria control 2006-2010: a comprehensive global assessment. Malar. J. 11:246.
17. Cappellini MD, Fiorelli G. 2008. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371:64-74.
18. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI. 2012. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 9:e1001339. doi:10.1371/journal.pmed.1001339.
19. Abeyaratne KP, Halpe NL. 1968. Sensitivity to primaquine in Ceylonese children due to deficiency of erythrocytic glucose-6-phosphate dehydrogenase. Ceylon Med. J. 27:134-138.
20. Burgoine KL, Bancone G, Nosten F. 2010. The reality of using primaquine. Malar. J. 9:376.
21. Baird JK, Hoffman SL. 2004. Primaquine therapy for malaria. Clin. Infect. Dis. 39:1336-1345.
22. Goller JL, Jolley D, Ringwald P, Biggs BA. 2007. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Am. J. Trop. Med. Hyg. 76:203-207.
23. Galappaththy GN, Omari AA, Tharyan P. 2007. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database Syst. Rev. 2007:CD004389.
24. Kitchen SF. 1949. Chapters 40 -43, p 966-1045. In Boyd MF (ed), Malariology: a comprehensive survey of all aspects of this group of diseases from a global standpoint, vol. II. W B Saunders Company, Philadelphia, PA.
25. Dhingra N, Jah P, Sharma VP, Cohen AA, Jotkar RM, Rodriguez PS, Bassani DG, Suraweera W, Laxminaryan R, Peto R. 2010. Adult and child mortality in India. Lancet 376:1768-1774.
26. World Health Organization. 2008. World malaria report 2008, p 1-190. WHO/HTM/GMP/20081. World Health Organization, Geneva, Switzerland.
27. Hay SI, Gething PW, Snow RW. 2010. India's invisible malaria burden. Lancet 376:1716-1717.
28. Elyazar IRF, Hay SI, Baird JK. 2011. Malaria distribution, prevalence, drug resistance and control in Indonesia. Adv. Parasitol. 74:41-175.
29. Elyazar IRF, Gething PW, Patil AP, Royagah H, Kusriastuti R, Wismarini DM, Tarmizi SN, Baird JK, Hay SI. 2011. Plasmodium falciparum malaria endemicity in Indonesia in 2010. PLoS One 6:e21315. doi: 10.1371/journal.pone.0021315.
30. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. 2012. Global mortality between 1980 and 2010: a systematic analysis. Lancet 379:413-431.
31. Doolan DL, Dobaño C, Baird JK. 2009. Acquired immunity to malaria. Clin. Microbiol. Rev. 22:13-36.
32. Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E. 2005. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar. J. 4:27.
33. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q. 2010. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar. J. 9:254.
34. Sternberg GM. 1884. Malaria and malarial diseases. William Wood & Company, New York, NY.
35. Coatney GR, Collins WE, Warren M, Contacos PG. 1971. The primate malarias. US Government Printing Office, Washington, DC.
36. Harrison GA. 1978. Mosquitoes, malaria & man: a history of the hostilities since 1880. E P Dutton, New York, NY.
37. Ewing J. 1902. Contribution to the pathological anatomy of malaria fever. J. Exp. Med. 6:119-180.
38. Covell G, Russell PF, Swellengrebel NH. 1953. Malaria terminology: report of a drafting committee appointed by the World Health Organization. WHO series 13. WHO, Geneva, Switzerland.
39. Wilcox A. 1960. Manual for the microscopical diagnosis of malaria in man. US Government Printing Office, Washington, DC.
40. Nicol WD. 1956. General paralysis of the insane. Br. J. Vener. Dis. 32:9-16.
41. Nicol WD. 1932. General paralysis: report of 579 case treated by malaria in the London County mental hospitals. Br. J. Psychiatry 78:946.
42. James SP, Nicol WD, Shute PG. 1936. Clinical and parasitological observation on induced malaria. Proc. R. Soc. Med. 29:879-894.
43. Nicol WD. 1927. The care and management of induced malaria. J. Mental Sci. 73:209-217.
44. Nicol WD. 1932. A review of 7 year's malaria therapy in general paralysis. J. Mental Sci. 78:843-866.
45. Fong TCC. 1937. A study of the mortality rate and complications following therapeutic malaria. South. Med. J. 30:1084-1088.
46. Martin JP. 1972. Conquest of general paralysis. Br. Med. J. 3:159-160.
47. Nicol WD. 1929. The treatment of general paralysis by malaria. Br. J. Vener. Dis. 5:85-94.
48. Kragh JV. 2010. Malaria therapy for general paralysis of the insane in Denmark. Hist. Psychiatry 21:471-486.
49. O'Leary PA, Welsh AL. 1933. Treatment of neurosyphilis with malaria: observations on nine hundred and eighty-four cases in the last nine years. JAMA 101:489-501.
50. Karnosh LJ, Williams GH. 1935. Some unusual complications in malaria therapy. Ohio State Med. J. 31:193.
51. Haskins J. 1931. Review of 100 malarial treated cases of general paralysis. Psychiatry Q. Albany 5:193.
52. Krauss W. 1932. Analysis of reports of 8,354 cases IMPF-malaria. South. Med. J. 25:537-541.
53. Reid B. 1932. General paralysis: result of eight years of malarial therapy. Br. J. Psychiatry 78:867-877.
54. Lilly GA. 1925. Treatment of general paralysis at Hanwell Mental Hospital Br. J. Psychiatry 71:267-278.
55. Rudolf GM. 1936. Recent advances in therapeutic (induced) malaria. J. Neurol. Psychopathol. 16:239-255.
56. Nicol WD. 1933. The relation of syphilis to mental disorder and the treatment of G.P.I. by malaria. Br. J. Vener. Dis. 9:219-229.
57. James SP, Nicol WD, Shute PG. 1932. A study of induced malignant tertian malaria. Proc. R. Soc. Med. XX:1153-1186.
58. Garnham PC, Bray RS, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Sergiev PG, Tiburskaja NA, Shute PG, Maryon M. 1975. A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull. World Health Organ. 52:21-32.
59. Dauer CC, Faust EC. 1937. Malaria mortality in the United States, with special reference to the southeastern states. South. Med. J. 30:939-943.
60. Prokopenko LI. 1959. On epidemiology of fulminant P. vivax malaria, p 80-102. In Beklemishev VN, RashinaMG(ed), Transactions of the Moscow Martinovski Institute of Medical Parasitology and Tropical Medicine. Institute of Medical Parasitology and Tropical Medicine, Moscow, Russia. (In Russian.)
61. Lysenko AY. 1960. Use of quinocide in treatment and prophylaxis of vivax malaria. Bull. World Health Organ. 22:641-662.
62. Swellengrebel NH. 1950. The malaria epidemic of 1943-1946 in the province of North Holland. Trans. R. Soc. Trop. Med. Hyg. 43:445-461.
63. Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. 1997. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans. R. Soc. Trop. Med. Hyg. 91:256-262.
64. Hyman A. 1945. Clinical masquerade of malaria. U. S. Navy Med. Bull. 45:287-303.
65. Most H, Hayman JM, Jr. 1946. Uncommon clinical manifestations of vivax malaria. JAMA 130:480-485.
66. Romanenko AP. 1936. Two cases of comatose from tertian malaria. Med. Parazitol. (Mosk.) 5:925-926. (In Russian.)
67. Tarajev EM, Gontayeva AA, Rotenburg SS. 1943. Fulminating type of tertian malaria. Sov. Med. 4:12-14. (In Russian.)
68. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. 1992. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U. S. A. 89:3200-3203.
69. Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M, Reisinger EC. 2006. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop. Med. Int. Health 11:817-823.
70. Perera MK, Carter R, Goonewardene R, Mendis KN. 1994. Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms. J. Exp. Med. 179:311-315.
71. Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, Kenangalem E, Price RN, Anstey NM. 2010. Greater endothelial activation, Weibel- Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. J. Infect. Dis. 202:109-112.
72. Seoh JY, Khan M, Park SH, Park HK, Shin MH, Ha EH, Lee BE, Yoo K, Han HS, Oh S, Wi JH, Hong CK, Oh CH, Kim YA, Park JW. 2003. Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hyperpyrexia. Am. J. Trop. Med. Hyg. 68:102-106.
73. Valecha N, Bagga A, Chandra J, Sharma D. 1992. Cerebral symptoms with P. vivax malaria. Indian Pediatr. 29:1176-1178.
74. Yale SH, Adlakha A, Sebo TJ, Ryu JH. 1993. Bronchiolitis obliterans organizing pneumonia caused by Plasmodium vivax malaria. Chest 104: 1294-1296.
75. Munteis E, Mellibovsky L, Marquez MA, Minguez S, Vazquez E, Diez A. 1997. Pulmonary involvement in a case of Plasmodium vivax malaria. Chest 111:834-835.
76. Torres JR, Perez H, Postigo MM, Silva JR. 1997. Acute non-cardiogenic lung injury in benign tertian malaria. Lancet 350:31-32.
77. Curlin ME, Barat LM, Walsh DK, Granger DL. 1999. Non-cardiogenic pulmonary edema during vivax malaria. Clin. Infect. Dis. 28:1166-1167.
78. Hsieh S, Babl FE. 1999. Vivax malaria complicated by adult respiratory distress syndrome. Clin. Infect. Dis. 28:1182-1184.
79. Tanios MA, Kogelman L, McGovern B, Hassoun PM. 2001. Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit. Care Med. 29:665-667.
80. Beg MA, Khan R, Baig SM, Gulzar Z, Hussain R, Smego RA, Jr. 2002. Cerebral involvement in benign tertian malaria. Am. J. Trop. Med. Hyg. 67:230-232.
81. Makkar RP, Mukhopadhyay S, Monga A, Gupta AK. 2002. Plasmodium vivax malaria presenting with severe thrombocytopenia. Braz. J. Infect. Dis. 6:263-265.
82. Lawn SD, Krishna S, Jarvis JN, Joet T, Macallan DC. 2003. Case reports: pernicious complications of benign tertian malaria. Trans. R. Soc. Trop. Med. Hyg. 97:551-553.
83. Spudick JM, Garcia LS, Graham DM, Haake DA. 2005. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax. J. Clin. Microbiol. 43:978-981.
84. Habib AG, Singh KS. 2004. Respiratory distress in nonimmune adults with imported malaria. Infection 32:356-359.
85. Lomar AV, Vidal JE, Lomar FP, Barbas CV, de Matos GJ, Buolos M. 2005. Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz. J. Infect. Dis. 9:425-430.
86. Thapa R, Patra V, Kundu R. 2007. Plasmodium vivax cerebral malaria. Indian Pediatr. 44:433-434.
87. Ozen M, Gungor S, Atambay M, Daldal N. 2006. Cerebral malaria owing to Plasmodium vivax: case report. Ann. Trop. Paediatr. 26:141-144.
88. Illamperuma C, Allen BL. 2007. Pulmonary edema due to Plasmodium vivax malaria in an American missionary. Infection 35:374-376.
89. Maguire JD, Fenton ME, Susanti AI, Walker JB. 2007. Plasmodium vivax-associated acute respiratory distress syndrome after extended travel in Afghanistan. Travel Med. Infect. Dis. 5:301-305.
90. Song JY, Park CW, Jo YM, Kim JY, Kim JH, Yoon HJ, Kim CH, Lim CS, Cheong HJ, Kim WJ. 2007. Two cases of Plasmodium vivax malaria with the clinical picture resembling toxic shock. Am. J. Trop. Med. Hyg. 77:609-611.
91. Kumar S, Melzer M, Dodds P, Watson J, Ord R. 2007. P. vivax malaria complicated by shock and ARDS. Scand. J. Infect. Dis. 39:255-256.
92. Price L, Planche T, Rayner C, Krishna S. 2007. Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans. R. Soc. Trop. Med. Hyg. 101:655-659.
93. Agarwal R, Nath A, Gupta D. 2007. Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Intern. Med. 46:2007-2011.
94. Sarkar S, Bhattacharya P. 2008. Cerebral malaria caused by Plasmodium vivax in adult subjects. Indian J. Crit. Care Med. 12:204-205.
95. Lacerda MV, Hipolito JR, Passos LN. 2008. Chronic Plasmodium vivax infection in a patient with splenomegaly and severe thrombocytopenia. Rev. Soc. Bras. Med. Trop. 41:522-523.
96. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP. 2005. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA 293:212-216.
97. Rifakis PM, Hernandez O, Fernandez CT, Rodriguez-Morales AJ, Von A, Franco-Paredes C. 2008. Atypical Plasmodium vivax malaria in a traveler: bilateral hydronephrosis, severe thrombocytopenia, and hypotension. J. Travel Med. 15:119-121.
98. Tan LK, Yacoub S, Scott S, Bhagani S, Jacobs M. 2008. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect. Dis. 8:449-454.
99. Thapa R, Biswas B, Mallick D, Sardar S, Modak S. 2009. Childhood Plasmodium vivax malaria with severe thrombocytopenia and bleeding manifestations. J. Pediatr. Hematol. Oncol. 31:758-759.
100. Valecha N, Pinto RG, Turner GD, Kumar A, Rodrigues S, Dubhashi NG, Rodrigues E, Banaulikar SS, Singh R, Dash AP, Baird JK. 2009. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 81:758-762.
101. Kasliwal P, Rao MS, Kujur R. 2009. Plasmodium vivax malaria: an unusual presentation. Indian J. Crit. Care Med. 13:103-105.
102. Kochar SK, Mahajan M, Gupta RP, Middha S, Acharya J, Kochar A, Das A, Kochar DK. 2009. Acute attack of AIP (acute intermittent porphyria) with severe vivax malaria associated with convulsions: a case report. J. Vector Borne Dis. 46:307-309.
103. Harish R, Gupta S. 2009. Plasmodium vivax malaria presenting with severe thrombocytopenia, cerebral complications and hydrochepalus. Indian J. Pediatr. 76:551-552.
104. Kim SA, Kim ES, Rhee MY, Choi SI, Huh HJ, Chae SL. 2009. A case of myocarditis associated with Plasmodium vivax malaria. J. Travel Med. 16:138-140.
105. Sarkar S, Saha K, Das CS. 2010. Three cases of ARDS: an emerging complication of Plasmodium vivax malaria. Lung India 27:154-157.
106. Siqueira AM, Alexandre MA, Mourao MP, Santos VS, Nagahashi- Marie SK, Alecrim MG, Lacerda MV. 2010. Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon. Am. J. Trop. Med. Hyg. 83:271-273.
107. Bhatia V, Bhatia J. 2010. Severe thrombocytopenia with bleeding manifestations in two children secondary to Plasmodium vivax. Platelets 21: 307-309.
108. Zaki SA, Shanbag P. 2011. Acute glomerulonephritis: an unusual manifestation of Plasmodium vivax malaria. Ann. Trop. Paediatr. 31:181-184.
109. Kute VB, Vanikar AV, Ghuge PP, Goswami JG, Patel MP, Patel HV, Gumber MR, Shah PR, Trivedi HL. 2012. Renal cortical necrosis and acute kidney injury associated with Plasmodium vivax: a neglected human parasite. Parasitol. Res. 111:2213-2216.
110. Choi HJ, Lee SY, Yang H, Bang JK. 2004. Retinal haemorrhage in vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 98:387-389.
111. Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. 2005. Plasmodium vivax malaria. Emerg. Infect. Dis. 11:132-134.
112. Pineros-Jimenez JG, Arboleda M, Jaramillo JC, Blair S. 2008. Report of five cases of severe neonatal Plasmodium vivax malaria in Uraba, Colombia. Biomedica 28:471-479.
113. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V. 2009. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am. J. Trop. Med. Hyg. 80:194-198.
114. Metanat M, Sharifi-Mood B. 2010. Malaria vivax and severe thrombocytopenia in Iran. Iran. J. Parasitol. 5:69-70.
115. Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, Lacerda MV, Alecrim MG. 2010. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg. Infect. Dis. 16:1611-1614.
116. Nayak KC, Mohini Kumar S, Tanwar RS, Kulkarni V, Gupta A, Sharma P, Sirohi P, Ratan P. 2011. A study on pulmonary manifestations in patients with malaria from northwestern India (Bikaner). J. Vector Borne Dis. 48:219-223.
117. Sinha A, Singh G, Bhat AS, Mohapatra S, Gulati A, Hari P, Samantaray JC, Dinda AK, Agaarwasl SK, Bagga A. Thrombotic microangiopathy and acute kidney injury following vivax malaria. Clin. Exp. Nephrol., in press.
118. Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Patel HV, Goswami JG, Kanodia KV. 2012. Plasmodium vivax malaria-associated acute kidney injury, India, 2010-2011. Emerg. Infect. Dis. 18:842-845.
119. Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, Siquiera AM, Ferreira LC, Aroujo JR, Mourao MP, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, del Portillo H, Ordi J, Alonso PL, Bassat Q. 2012. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin. Infect. Dis. 55:e67-e74.
120. Oh MD, Shin H, Shin D, Kim U, Lee S, Kim N, Choi MH, Chai JY, Choe K. 2001. Clinical features of vivax malaria. Am. J. Trop. Med. Hyg. 65:143-146.
121. Koh KH, Chew PH, Kiyu A. 2004. A retrospective study of malaria infections in an intensive care unit of a general hospital in Malaysia. Singapore Med. J. 45:28-36.
122. Barcus MJ, Basri H, Picarima H, Manyakori C, Sekartuti Elyazar I, Bangs MJ, Maguire JD, Baird JK. 2007. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am. J. Trop. Med. Hyg. 77:984-991.
123. Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, Menezes E, Hussain R, Smego R, Jr. 2008. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan. Int. J. Infect. Dis. 12:37-42.
124. Sharma A, Khanduri U. 2009. How benign is benign tertian malaria? J. Vector Borne Dis. 46:141-144.
125. Rodriguez-Morales AJ, Ferrer MV, Barrera MA, Pacheco M, Daza V, Franco-Paredes C. 2009. Imported cases of malaria admitted to two hospitals of Margarita Island, Venezuela, 1998-2005. Travel Med. Infect. Dis. 7:44-48.
126. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, O'Brien C, Bassat Q, Lacerda MV. 2012. Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One 7:e35406. doi:10.1371/journal.pone.0035406.
127. Sharma R, Gohain S, Chandra J, Kumar V, Chopra A, Chatterjee S, Aneja S, Kumar DA. 2012. Plasmodium vivax malaria admissions and risk for mortality in tertiary care children's hospital in north India. Paediatr. Int. Child Health 32:152-157.
128. Nurleila S, Syafruddin D, Elyazar IRF, Baird JK. 2012. Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba in eastern Indonesia. Am. J. Trop. Med. Hyg. 87:41-49.
129. Shaikh S, Memon H, Shaikh A, Ahmed I, Iohano B, Baird JK. 2012. Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in south-eastern Pakistan. Malar. J. 11:144.
130. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN. 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 5:e128. doi:10.1371/journal.pmed.0050128.
131. Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, Gupta A, Kochar A, Middha S, Acharya J, Saxena V, Pakalapati D, Garg S, Das A. 2010. Clinical features of children hospitalized with malaria-a study from Bikaner, northwest India. Am. J. Trop. Med. Hyg. 83:981-989.
132. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarencio J, Camargo LM, Barral A, Barral-Netto M. 2010. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar. J. 9:13.
133. Mahgoub H, Gasim GI, Musa IR, Adam I. 2012. Severe Plasmodium vivax among Sudanese children at New Halfa Hospital, eastern Sudan. Parasites Vectors 5:154.
134. Kaushik JS, Gomber S, Dewan P. 2012. Clinical and epidemiological profiles of severe malaria in children from Delhi, India. J. Health Popul. Nutr. 30:113-116.
135. Manning L, Laman M, Law I, Bona C, Aipit S, Teine D, Warrell J, Rosanas-Urgell A, Lin E, Kiniboro B, Vince J, Hwaiwhanje I, Karunajeewa H, Michon P, Siba P, Mueller I, Davis TM. 2011. Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One 6:e29203. doi:10.1371/journal.pone.0029203.
136. Genton B, D'Acremont V, Rare L, Bae K, Reeder JC, Alpers MP, Muller I. 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5:e127. doi:10.1371/journal.pmed.0050127.
137. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN. 2008. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. J. Infect. Dis. 46:1374-1381.
138. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, Warikar N, Sugiarto P, Tjitra E, Anstey NM, Price RN. 2009. Vivax malaria: a major cause of morbidity in early infancy. Clin. Infect. Dis. 48:1704-1712.
139. McGready R, Lee SJ, Wiladphaingern J, Ashley EA, Rijken MJ, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH. 2012. Adverse effects of falciparum and vivax malaria and the safety of antimalarial drug treatment in early pregnancy: a population-based study. Lancet Infect. Dis. 12:388-396.
140. Anstey NM, Russell B, Yeo TW, Price RN. 2009. The pathophysiology of vivax malaria. Trends Parasitol. 25:220-227.
141. Price RN, Douglas NM, Anstey NM. 2009. New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr. Opin. Infect. Dis. 22:430-435.
142. Russell PF. 1955. Man's mastery of malaria. Oxford University Press, Oxford, United Kingdom.
143. Baird JK. 2000. Resurgent malaria at the millennium: control strategies in crisis. Drugs 59:719-743.
144. Rodriguez JC, Uribe GA, Araujo RM, Narvaez PC, Valencia SH. 2011. Epidemiology and control of malaria in Colombia. Mem. Inst. Oswaldo Cruz 106(Suppl 1):114-122.
145. Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F. 2006. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med. 3:e183. doi:10.1371/journal.pmed.0030183.
146. Park JW, Jun G, Yeom JS. 2009. Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J. Parasitol. 47(Suppl):S39-S50.
147. Baird JK. 2012. Reinventing primaquine for endemic malaria. Expert Opin. Emerg. Drugs 17:439-444.
148. Baird JK. 2012. Elimination therapy for the endemic malarias. Curr. Infect. Dis. Rep. 14:227-237.
149. Baird JK. 2012. Tropical health sustainability, p 11134-11163. In Meyers RA (ed), Encyclopedia of sustainability science and technology. Springer Verlag, New York, NY.
150. Jensen JB, Trager W. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
151. Rubach MP, Mukemba J, Florence S, John B, Crookston B, Lopansri BK, Yeo TW, Piera KA, Alder SC, Weinberg JB, Anstey NM, Granger DL, Mwaikambo ED. 2012. Plasma Plasmodium falciparum histidinerich protein-2 concentrations are associated with malaria severity and mortality in Tanzanian children. PLoS One 7:e35985. doi:10.1371 /journal.pone.0035985.
152. Silamut K, White NJ. 1993. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 87:436-443.
153. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PR, Pitisuttithum P, Smithyman AM, White NJ, Day NP. 2005. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2:e204. doi:10.1371/journal.pmed.0020204.
154. Hanson J, Lam SW, Mahanta KC, Pattnaik R, Alam S, Mohanty S, Hasan MU, Hossain A, Charunwatthana P, Chotivanich K, Maude RJ, Kingston H, Day NP, Mishra S, White NJ, Dondorp AM. 2012. Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. J. Infect. Dis. 206:571-579.
155. Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, Price RN, Engwerda CR, Anstey PM, Plebanski M. 2009. Parasitedependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog. 5:e1000402. doi:10.1371/journal.ppat.1000402.
156. Sherry BA, Alava G, Tracey KJ, Martiney J, Cerami A, Slater AF. 1995. Malaria-specific metabolite hemozoin mediates the release of several potent pyrogens (TNF, MIP-1 alpha and MIP-1 beta) in vitro, and altered thermoregulation in vivo. J. Inflamm. 45:85-96.
157. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanely M, Marsh V, Newton C, Winstanley P, Warn P, Peshu N, Pasvol G, Snow R. 1995. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 332:1399-1404.
158. Miller LH, Baruch DI, Marsh K, Doumbo OK. 2002. The pathogenic basis of malaria. Nature 415:673-679.
159. Kirchgatter K, del Portillo HA. 2005. Clinical and molecular aspects of severe malaria. Ann. Braz. Acad. Sci. 77:455-475.
160. Miller LH, Good MF, Milon G. 1994. Malaria pathogenesis. Science 264:1178-1183.
161. Costa FT, Lopes SC, Ferrer M, Leite JA, Martin-Jaular L, Bernabeu M, Nogueira PA, Mourao MP, Fernandez-Becerra C, Lacerda MV, del Portillo H. 2011. On cytoadhesion of Plasmodium vivax: raison d'etre? Mem. Inst. Oswaldo Cruz 106(Suppl 1):79-84.
162. Genrich GL, Guarner J, Paddock CD, Shieh WJ, Greer PW, Barnwell JW, Zaki SR. 2007. Fatal malaria infection in travelers: novel immunohistochemical assays for the detection of Plasmodium falciparum in tissues and implications for pathogenesis. Am. J. Trop. Med. Hyg. 76:251-259.
163. Suwanarusk R, Cooke BM, Dondorp AM, Silamut K, Sattabongkot J, White NJ, Udomsangpetch R. 2004. The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J. Infect. Dis. 189: 190-194.
164. Handayani S, Chiu DT, Tjitra E, Kuo JS, Lampah D, Kenangalem E, Renia L, Snounou G, Price RN, Anstey NM, Russell B. 2009. High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J. Infect. Dis. 199:445-450.
165. Chamberlain JK, Lichtman MA. 1978. Marrow cell egress: specificity of the site of penetration into the sinus. Blood 52:959-968.
166. Yoeli M. 1948. Non-pigmented malaria parasites in the bone marrow from a mixed infection of leishmania and plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg. 42:99.
167. Ru YX, Mao BY, Zhang FK, Pang TX, Zhao SX, Liu JH, Wickramasinghe SN. 2009. Invasion of erythroblasts by Plasmodium vivax: a new mechanism contributing to malarial anemia. Ultrastruct. Pathol. 33: 236-242.
168. Imirzalioglu C, Soydan N, Schaller M, Bretzel RG, Chakraborty T, Domann E. 2006. Diagnosis of mixed Plasmodium malariae and P. vivax infection in a development aid volunteer by examination of bonemarrow specimens by real-time PCR. J. Clin. Microbiol. 44:2307-2310.
169. O'Donnell J, Goldman JM, Wagner K, Ehinger G, Martin N, Leahy M, Kariuki N, Dokal I, Roberts I. 1998. Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation. Bone Marrow Transplant. 21:313-314.
170. Panichakul T, Sattabongkot J, Chotivanich K, Sirichaisinthop J, Cui L, Udomsangpetch R. 2007. Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int. J. Parasitol. 37:1551-1557.
171. Wickramasinghe SN, Abdalla SH. 2000. Blood and bone marrow changes in malaria. Baillieres Best Pract. Res. Clin. Haematol. 13:277-299.
172. del Portillo HA, Lanzer M, Rodriquez-Malaga S, Zavala F, Fernadez- Becerra C. 2004. Variant genes and the spleen in Plasmodium vivax malaria. Int. J. Parasitol. 34:1547-1554.
173. Imbert P, Rapp C, Buffet PA. 2009. Pathological rupture of the spleen in malaria: analysis of 55 cases (1958-2008). Travel Med. Infect. Dis. 7:147-159.
174. Anderson F, Douglas NM, Bustos D, Galappaththy G, Qi G, Hsiang MS, Kusriastuti R, Mendis K, Taleo G, Whittaker M, Price RN, von Seidlin L. 2011. Trends in malaria research in 11 Asian Pacific countries: an analysis of peer-reviewed publications over two decades. Malar. J. 10:131. doi:10.1186/1475-2875-10-131.
175. Siqueira AM, Magalhaes BM, Melo GC, Ferrer M, Castillo P, Martin- Jaular L, Fenandez-Becerra C, Ordi J, Martinez A, Larcerda MVG, del Portillos HA. 2012. Spleen rupture in a case of untreated Plasmodium vivax infection. PLoS Negl. Trop. Dis. 6(12):e1934. doi:10.1371/journal.pntd.0001934.